Gottfried E. Konecny
University of California, Los Angeles(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Cancer Genomics and Diagnostics, Endometrial and Cervical Cancer Treatments, HER2/EGFR in Cancer Research
Most-Cited Works
- → Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes(2012)2,632 cited
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial(2016)1,190 cited
- → Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells(2006)906 cited
- → Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology(2021)695 cited
- → Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer(2003)589 cited